JP2019530729A5 - - Google Patents

Download PDF

Info

Publication number
JP2019530729A5
JP2019530729A5 JP2019520647A JP2019520647A JP2019530729A5 JP 2019530729 A5 JP2019530729 A5 JP 2019530729A5 JP 2019520647 A JP2019520647 A JP 2019520647A JP 2019520647 A JP2019520647 A JP 2019520647A JP 2019530729 A5 JP2019530729 A5 JP 2019530729A5
Authority
JP
Japan
Prior art keywords
composition according
liposome
phospholipid
composition
topical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019520647A
Other languages
English (en)
Japanese (ja)
Other versions
JP7042262B2 (ja
JP2019530729A (ja
Filing date
Publication date
Priority claimed from IT102016000103956A external-priority patent/IT201600103956A1/it
Application filed filed Critical
Publication of JP2019530729A publication Critical patent/JP2019530729A/ja
Publication of JP2019530729A5 publication Critical patent/JP2019530729A5/ja
Application granted granted Critical
Publication of JP7042262B2 publication Critical patent/JP7042262B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019520647A 2016-10-17 2017-10-16 緑内障の治療のための、リポソームによって担持されるシチコリンを含む眼科用処方 Active JP7042262B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102016000103956A IT201600103956A1 (it) 2016-10-17 2016-10-17 Formulazione oftalmica comprendente citicolina veicolata da liposomi per il trattamento del glaucoma
IT102016000103956 2016-10-17
PCT/IB2017/056400 WO2018073720A1 (en) 2016-10-17 2017-10-16 Ophthalmic formulation comprising citicoline carried by liposome for the treatment of glaucoma

Publications (3)

Publication Number Publication Date
JP2019530729A JP2019530729A (ja) 2019-10-24
JP2019530729A5 true JP2019530729A5 (enExample) 2020-11-05
JP7042262B2 JP7042262B2 (ja) 2022-03-25

Family

ID=58010202

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019520647A Active JP7042262B2 (ja) 2016-10-17 2017-10-16 緑内障の治療のための、リポソームによって担持されるシチコリンを含む眼科用処方

Country Status (9)

Country Link
US (1) US10576039B2 (enExample)
EP (1) EP3525758B1 (enExample)
JP (1) JP7042262B2 (enExample)
EA (1) EA201990752A1 (enExample)
ES (1) ES2987910T3 (enExample)
IT (1) IT201600103956A1 (enExample)
MX (1) MX388927B (enExample)
TN (1) TN2019000112A1 (enExample)
WO (1) WO2018073720A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20251646T1 (hr) 2017-06-09 2026-02-13 Omnivision Gmbh Pripravak za liječenje suhog oka
IT201800005309A1 (it) * 2018-05-11 2019-11-11 Composizione ad attivita’ antimicrobica
CN110559261A (zh) * 2018-06-06 2019-12-13 常州药物研究所有限公司 含有纳米交联透明质酸的脂质体微乳及其制备方法和应用
CN111840220B (zh) * 2020-08-19 2022-09-30 开封康诺药业有限公司 一种胞磷胆碱钠注射液及其制备方法
MX2023013266A (es) * 2021-05-10 2023-12-15 Omikron Italia S R L Solucion oral basada en citicolina y nicotinamida para usar en el tratamiento del glaucoma.
WO2025037323A1 (en) * 2023-08-12 2025-02-20 Pavan Kumar Kothapuvari Pharmaceutical compositions for treatment of dry eye disease and associated disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0114577A1 (en) * 1983-01-21 1984-08-01 MAGIS FARMACEUTICI S.p.A. New pharmaceutical composition
JPWO2002034252A1 (ja) * 2000-10-26 2004-03-04 千寿製薬株式会社 ジペプチジルアルデヒド誘導体含有医薬組成物
WO2010092597A2 (en) * 2009-02-11 2010-08-19 Lyka Labs Limited Liposomal citicoline injection
IT1398378B1 (it) * 2010-02-22 2013-02-22 Omikron Italia S R L Citicolina per il trattamento del glaucoma e dell'ipertensione oculare.
FR2961694B1 (fr) 2010-06-29 2013-01-25 Thea Lab Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur
WO2012021107A2 (en) * 2010-08-12 2012-02-16 Nanyang Technological University A liposomal formulation for ocular drug delivery
CN102078299B (zh) * 2011-01-04 2012-09-26 海南美大制药有限公司 胞磷胆碱钠脂质体固体制剂

Similar Documents

Publication Publication Date Title
JP2013535472A5 (enExample)
JP2023017050A5 (enExample)
ES2803648T3 (es) Composiciones farmacéuticas acuosas que contienen complejos de borato-poliol
JP6014033B2 (ja) 防腐剤無添加ビマトプロストおよびチモロール溶液
ATE428401T1 (de) Suspensionsformulierungen mit einem aktiven wirkstoff, einem poloxamer- oder meroxapol-tensid und einem glycol und ihre verwendung zur herstellung eines medikaments zur behandlung von augenkrankheiten
WO2008011164A2 (en) Methods and compositions for the treatment and prevention of infections
RU2010141542A (ru) Низковязкие высокофлокулированные суспензии триамцинолона ацетонида для интравитреальных инъекций
WO2008083256A2 (en) Ophthalmic and otic compositions of facially amphiphilic polymers and oligomers and uses thereof
JP2019532105A5 (enExample)
JP2009538287A5 (ja) 低粘度グリコサミノグリカンで構成される組成物及び該組成物の間質性膀胱炎の治療での使用
JP2014515383A5 (enExample)
JP2002539153A5 (enExample)
JP2021522264A (ja) 抗微生物有効性の増強及び毒性の減少を有する亜塩素酸ナトリウム組成物
JP2003146891A (ja) 洗浄剤
JPS6410500B2 (enExample)
EP2598117A2 (en) Preservative free bimatoprost solutions
ES2791360T3 (es) Composiciones oftálmicas que comprenden iota-carragenina
CN101674849A (zh) N-卤代的氨基酸制剂
CN102858352B (zh) 含有鏻抗微生物剂的药物组合物
US20090258946A1 (en) Electrostatically charged nasal application multipurpose products and method
ES2974884T3 (es) Composición de colirio para reducir la presión intraocular
JP2023001184A5 (enExample)
JP6253756B2 (ja) 眼科用水性組成物
RU2442583C2 (ru) Стабилизированные и консервированные глазные композиции, содержащие кетотифен
ES2700775T3 (es) Composiciones oftálmicas acuosas que contienen agentes terapéuticos aniónicos